These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 2431362

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cholinergic lesions of the rat brain by ibotenic acid and 192 IgG-saporin: effects on somatostatin, substance P and neuropeptide Y levels in the cerebral cortex and the hippocampus.
    Nag S, Tang F.
    Neurosci Lett; 1998 Aug 14; 252(2):83-6. PubMed ID: 9756327
    [Abstract] [Full Text] [Related]

  • 4. Acetylcholinesterase fibers and the development of senile plaques.
    Tago H, McGeer PL, McGeer EG.
    Brain Res; 1987 Mar 17; 406(1-2):363-9. PubMed ID: 3567634
    [Abstract] [Full Text] [Related]

  • 5. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.
    Henke H, Lang W.
    Brain Res; 1983 May 16; 267(2):281-91. PubMed ID: 6871677
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
    Rossor MN, Svendsen C, Hunt SP, Mountjoy CQ, Roth M, Iversen LL.
    Neurosci Lett; 1982 Feb 12; 28(2):217-22. PubMed ID: 7070710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.
    Rossor M, Fahrenkrug J, Emson P, Mountjoy C, Iversen L, Roth M.
    Brain Res; 1980 Nov 10; 201(1):249-53. PubMed ID: 7417838
    [Abstract] [Full Text] [Related]

  • 10. A post-mortem study of the cholinergic and GABA systems in senile dementia.
    Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL.
    Brain; 1982 Jun 10; 105(Pt 2):313-30. PubMed ID: 7082992
    [Abstract] [Full Text] [Related]

  • 11. Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia.
    Allen JM, Ferrier IN, Roberts GW, Cross AJ, Adrian TE, Crow TJ, Bloom SR.
    J Neurol Sci; 1984 Jun 10; 64(3):325-31. PubMed ID: 6147394
    [Abstract] [Full Text] [Related]

  • 12. A case of Alzheimer's disease and hippocampal sclerosis with normal cholinergic activity in basal forebrain, neocortex, and hippocampus.
    Zweig RM, Schegg KM, Peacock JH, Melarkey D.
    Neurology; 1989 Feb 10; 39(2 Pt 1):288-90. PubMed ID: 2915803
    [Abstract] [Full Text] [Related]

  • 13. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC, Ikonomovic MD, Brady DR, Mufson EJ, Armstrong DM.
    J Comp Neurol; 1993 Aug 08; 334(2):176-91. PubMed ID: 7690048
    [Abstract] [Full Text] [Related]

  • 14. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
    Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL.
    Neurosci Lett; 1980 Dec 08; 20(3):373-7. PubMed ID: 6108540
    [Abstract] [Full Text] [Related]

  • 15. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P, Katzman R, Terry RD.
    Nature; 1980 Nov 20; 288(5788):279-80. PubMed ID: 6107862
    [Abstract] [Full Text] [Related]

  • 16. Choline acetyltransferase and somatostatin levels in aged Microcebus murinus brain.
    Dournaud P, Gautron JP, Pattou E, Bons N, Mestre N, Petter A, Kordon C, Epelbaum J.
    Neurobiol Aging; 1994 Nov 20; 15(6):727-31. PubMed ID: 7891828
    [Abstract] [Full Text] [Related]

  • 17. Substance P and somatostatin coexist within neuritic plaques: implications for the pathogenesis of Alzheimer's disease.
    Armstrong DM, Benzing WC, Evans J, Terry RD, Shields D, Hansen LA.
    Neuroscience; 1989 Nov 20; 31(3):663-71. PubMed ID: 2480552
    [Abstract] [Full Text] [Related]

  • 18. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease.
    Foster NL, Tamminga CA, O'Donohue TL, Tanimoto K, Bird ED, Chase TN.
    Neurosci Lett; 1986 Jan 02; 63(1):71-5. PubMed ID: 3754039
    [Abstract] [Full Text] [Related]

  • 19. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
    Bird TD, Stranahan S, Sumi SM, Raskind M.
    Ann Neurol; 1983 Sep 02; 14(3):284-93. PubMed ID: 6227276
    [Abstract] [Full Text] [Related]

  • 20. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA, Davies P.
    J Neurochem; 1982 Jun 02; 38(6):1781-4. PubMed ID: 6176686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.